These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 9015212

  • 41. Tyrosine residues of the granulocyte colony-stimulating factor receptor transmit proliferation and differentiation signals in murine bone marrow cells.
    Akbarzadeh S, Ward AC, McPhee DO, Alexander WS, Lieschke GJ, Layton JE.
    Blood; 2002 Feb 01; 99(3):879-87. PubMed ID: 11806990
    [Abstract] [Full Text] [Related]

  • 42. STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation.
    McLemore ML, Grewal S, Liu F, Archambault A, Poursine-Laurent J, Haug J, Link DC.
    Immunity; 2001 Feb 01; 14(2):193-204. PubMed ID: 11239451
    [Abstract] [Full Text] [Related]

  • 43. The early administration of granulocyte colony-stimulating factor increases the engraftment of transplanted bone marrow-derived cells into the olfactory epithelium damaged by methimazole.
    Nishizaki K, Yoshinobu J, Tsujigiwa H, Orita Y, Yamada M.
    Rhinology; 2010 Jun 01; 48(2):228-32. PubMed ID: 20502766
    [Abstract] [Full Text] [Related]

  • 44. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia.
    Dong F, Hoefsloot LH, Schelen AM, Broeders CA, Meijer Y, Veerman AJ, Touw IP, Löwenberg B.
    Proc Natl Acad Sci U S A; 1994 May 10; 91(10):4480-4. PubMed ID: 7514305
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation.
    Dong F, Qiu Y, Yi T, Touw IP, Larner AC.
    J Immunol; 2001 Dec 01; 167(11):6447-52. PubMed ID: 11714811
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Therapeutic effect of granulocyte colony-stimulating factor (G-CSF) on the protection against Listeria infection in SCID mice.
    Kayashima S, Tsuru S, Hata N, Rokutanda M.
    Immunology; 1993 Nov 01; 80(3):471-6. PubMed ID: 7507094
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Defective in vitro migratory capacity of bone marrow cells from viable motheaten mice in response to normal thymus culture supernatants.
    Haar JL, Popp JD, Shultz LD.
    Exp Hematol; 1989 Jan 01; 17(1):21-4. PubMed ID: 2562796
    [Abstract] [Full Text] [Related]

  • 51. Granulocyte colony-stimulating factor shortens the optimal interval of repetition of chemotherapy with cyclophosphamide in mice.
    Hattori K, Tamura M, Ono M.
    In Vivo; 1996 Jan 01; 10(3):361-8. PubMed ID: 8797041
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Essential role for cyclin D3 in granulocyte colony-stimulating factor-driven expansion of neutrophil granulocytes.
    Sicinska E, Lee YM, Gits J, Shigematsu H, Yu Q, Rebel VI, Geng Y, Marshall CJ, Akashi K, Dorfman DM, Touw IP, Sicinski P.
    Mol Cell Biol; 2006 Nov 01; 26(21):8052-60. PubMed ID: 16954383
    [Abstract] [Full Text] [Related]

  • 54. Flow cytometric analysis of G-CSF receptors on normal white cells and leukemic cells.
    Yamane T, Im T, Tatsumi N, Okuda K.
    Osaka City Med J; 1993 Jun 01; 39(1):11-23. PubMed ID: 7694217
    [Abstract] [Full Text] [Related]

  • 55. Quantification of the cell kinetic effects of G-CSF using a model of human granulopoiesis.
    Schmitz S, Franke H, Brusis J, Wichmann HE.
    Exp Hematol; 1993 Jun 01; 21(6):755-60. PubMed ID: 7684699
    [Abstract] [Full Text] [Related]

  • 56. T-cell protein tyrosine phosphatase (Tcptp) is a negative regulator of colony-stimulating factor 1 signaling and macrophage differentiation.
    Simoncic PD, Bourdeau A, Lee-Loy A, Rohrschneider LR, Tremblay ML, Stanley ER, McGlade CJ.
    Mol Cell Biol; 2006 Jun 01; 26(11):4149-60. PubMed ID: 16705167
    [Abstract] [Full Text] [Related]

  • 57. A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns].
    Tian SS, Lamb P, King AG, Miller SG, Kessler L, Luengo JI, Averill L, Johnson RK, Gleason JG, Pelus LM, Dillon SB, Rosen J.
    Science; 1998 Jul 10; 281(5374):257-9. PubMed ID: 9657720
    [Abstract] [Full Text] [Related]

  • 58. Establishment and characterization of pro-B cell lines from motheaten mutant mouse defective in SHP-1 protein tyrosine phosphatase.
    Miyamoto A, Kunisada T, Yamazaki H, Miyake K, Nishikawa SI, Sudo T, Shultz LD, Hayashi SI.
    Immunol Lett; 1998 Sep 10; 63(2):75-82. PubMed ID: 9761368
    [Abstract] [Full Text] [Related]

  • 59. Molecular genetics and development of mast cells: implications for molecular medicine.
    Födinger M, Mannhalter C.
    Mol Med Today; 1997 Mar 10; 3(3):131-7. PubMed ID: 9095488
    [Abstract] [Full Text] [Related]

  • 60. Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells.
    Shimozaki K, Nakajima K, Hirano T, Nagata S.
    J Biol Chem; 1997 Oct 03; 272(40):25184-9. PubMed ID: 9312131
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.